Literature DB >> 2426676

Totally implantable spinal cord stimulation for chronic pain: design and efficacy.

D Shatin, K Mullett, G Hults.   

Abstract

Neurostimulators used to treat chronic, intractable pain have evolved from technical developments in pacemaker technology. A totally implantable spinal cord stimulation (SCS) system was designed based on elements of a widely used cardiac pacemaker. This paper reports on the transformation of pacemaker technology for neurostimulation applications and presents results of using this system for the treatment of 90 patients with chronic, intractable pain of the low back and/or legs. Significant reduction in pain levels resulted from use of a totally implantable spinal cord stimulation system. Seventy percent of the patients experienced good or excellent pain relief at an average of 14.5 months after implant. Patients who used an automatic ON/OFF cycling mode of stimulation reported greater pain relief than patients who were stimulated continuously.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426676     DOI: 10.1111/j.1540-8159.1986.tb06614.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  Spinal cord stimulation in 112 patients with epi-/intradural fibrosis following operation for lumbar disc herniation.

Authors:  C Probst
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

2.  A New Direction for Closed-Loop Spinal Cord Stimulation: Combining Contemporary Therapy Paradigms with Evoked Compound Action Potential Sensing.

Authors:  Ricardo Vallejo; Krishnan Chakravarthy; Andrew Will; Karen Trutnau; David Dinsmoor
Journal:  J Pain Res       Date:  2021-12-29       Impact factor: 2.832

Review 3.  Non-Pharmacological Therapeutic Options for the Treatment of Alzheimer's Disease.

Authors:  Quy-Susan Huynh; Shalini Elangovan; R M Damian Holsinger
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.